A predictive study of metabolism reprogramming in cervical carcinoma

Area of Science:

• Oncology
• Cancer Metabolism
• Immunology

Background:

• Metabolic reprogramming is a key hallmark of cancer, significantly influencing the tumor microenvironment's immune landscape.
• Cervical carcinoma exhibits high heterogeneity, necessitating the identification of distinct metabolic subtypes for prognostic insights.

Purpose of the Study:

• To investigate metabolic subtypes of cervical carcinoma and their association with patient prognosis.
• To identify metabolic biomarkers predictive of overall survival and chemotherapy resistance in cervical cancer.

Main Methods:

• Utilized transcriptomic data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets to profile metabolic signatures.
• Conducted bioinformatics analyses to identify prognostic biomarkers and assess immune infiltration related to metabolic pathways.

Main Results:

• Identified significant associations between immune infiltration and metabolic pathways, particularly carbohydrate and lipid/energy metabolism.
• Developed a risk score model based on six prognostic genes (ELK3, BIN2, MEI1, CCR7, CYP4F12, DUOX1), demonstrating that a high-risk group had significantly lower survival and higher chemotherapy resistance.
• Observed higher infiltration of anti-tumor immune cells in the high-risk group compared to the low-risk group.

Conclusions:

• Metabolic reprogramming, especially in carbohydrate and lipid/energy pathways, is linked to the immune microenvironment in invasive cervical carcinoma.
• These metabolic-immune interactions are critical for prognosis and represent potential therapeutic targets for invasive cervical carcinoma.